A Complex Chromosomal Rearrangement Involving Chromosomes X, 3, and 4 Characterized by Multi‐Platform Genomic Technologies
Molecular Genetics & Genomic Medicine · 2026-11 · 14 (11)
DOI: 10.1002/mgg3.70354 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 18.11.2026. Verfasst von Hualei Luo und 8 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Complex chromosomal rearrangements (CCRs) are rare structural alterations that can lead to growth failure and gonadal dysfunction. However, their phenotypic impact is often difficult to interpret, particularly in patients without congenital anomalies who present with unexplained short stature or gonadal dysgenesis.
Methods
We evaluated a female pediatric patient presenting with persistent short stature, delayed bone age, and biochemical and imaging evidence of gonadal dysgenesis. The study employed an integrated approach: conventional karyotyping was first used to detect large‐scale abnormalities, followed by optical genome mapping (OGM) for high‐resolution breakpoint analysis. Genomic findings were correlated with clinical, radiographic, and imaging data.
Results
Karyotyping revealed a complex rearrangement involving chromosomes X, 3, and 4. OGM further resolved the architecture, identifying nine breakpoints resulting in three derivative chromosomes, and permitting classification as a type C (exceptional) CCR corresponding to Madan group IV. Key genes disrupted or repositioned included LRBA, CFAP44, EPHA3, CADM2, GALNTL6, and DCBLD2. The complex breakpoint pattern suggested a catastrophic event, such as chromothripsis, during early embryogenesis. Despite this genomic complexity, the patient lacked major malformations or intellectual disability, manifesting primarily with Turner syndrome–like features; biochemical testing established hypergonadotropic hypogonadism, whereas the short stature remained unexplained after growth hormone provocation.
Conclusion
This case highlights the clinical utility of OGM in resolving cryptic CCRs elusive to conventional cytogenetics, while illustrating that extraction of maximal diagnostic information requires integration of structural, clinical and imaging data. It expands the phenotypic spectrum of CCRs, demonstrating that complex structural variants can be encountered in patients whose clinical presentation is otherwise confined to growth and gonadal manifestations, emphasizing the necessity of advanced genomic profiling for precise diagnosis and management.
Zitieren
APA
Luo, H., Huang, J., Hassan, R. N., Ye, Y., Liu, W., Wang, D., Fu, X., Chen, Y., & Xiao, W. (2026). A Complex Chromosomal Rearrangement Involving Chromosomes X, 3, and 4 Characterized by Multi‐Platform Genomic Technologies. Molecular Genetics & Genomic Medicine, 14(11). https://doi.org/10.1002/mgg3.70354
Vancouver
Luo H, Huang J, Hassan RN, Ye Y, Liu W, Wang D, et al. A Complex Chromosomal Rearrangement Involving Chromosomes X, 3, and 4 Characterized by Multi‐Platform Genomic Technologies. Molecular Genetics & Genomic Medicine. 2026;14(11). doi:10.1002/mgg3.70354
BibTeX
@article{Luo2026,
author = {Luo, Hualei and Huang, Juan and Hassan, Reem Nabil and Ye, Yuhua and Liu, Wei and Wang, Duocai and Fu, Xiaoying and Chen, Yunsheng and Xiao, Weiwei},
title = {A Complex Chromosomal Rearrangement Involving Chromosomes X, 3, and 4 Characterized by Multi‐Platform Genomic Technologies},
journal = {Molecular Genetics & Genomic Medicine},
year = {2026},
volume = {14},
number = {11},
doi = {10.1002/mgg3.70354}
}
EUVIMED